Cloned calves a first for Australia
27 March, 2002 by Melissa TrudingerIn a first for the Australian dairy industry, four genetically modified calves have been born with an additional protein gene for milk protein production.
Metabolic in trans-Tasman licensing, research deal
27 March, 2002 by Tanya HollisMetabolic Pharmaceuticals has announced a trans-Tasman licensing deal and research collaboration to develop a new osteoporosis treatment.
Xenome in third screening partnership
27 March, 2002 by Pete YoungBrisbane biotech and animal venom specialist Xenome Ltd has found yet another partner to screen its library of bioactive peptide molecules.
Victorian plant genetics company launched
26 March, 2002 by Tanya HollisMost of Australia's staple foods would be altered through genetic technologies within the next 20 years, according to one of the nation's most celebrated scientists.
Cyclotide research looks for new drugs
26 March, 2002 by Melissa TrudingerCyclotides are a unique group of plant proteins with unusual properties. Kalthera, a small Queensland biotech company, is developing technology to use them in therapeutic applications.
BASF Boosts Bioagriculture
26 March, 2002 by Daniella GoldbergAustralia's biotechnology industry may be in for a big boost after a team from BASF, an international plant and chemical company, visited to find potential collaborative ventures.
Hep C treatment targeted
25 March, 2002 by Tanya HollisThe US subsidiary of homegrown drug discovery group Biota Holdings has announced plans to focus on treatments for hepatitis C virus.
Bioprospecting company on the move
22 March, 2002 by Pete YoungBioProspect is expanding its beachead in Queensland on the back of promising results from its five-month-old biota mining agreement with the State Government.
Metabolic in iron drug deal
21 March, 2002 by Melissa TrudingerMelbourne biotechnology company Metabolic Pharmaceuticals (ASX:MBP) has entered into licence and research agreements with Sydney's Heart Research Institute (HRI) to develop a drug for the treatment of iron overload diseases.
Skin doctor joins tanning tech company
21 March, 2002 by Tanya HollisA leading dermatologist has joined the board of the Australian company behind a new tanning drug.
Australian research makes a play in the post-genomic era
20 March, 2002 by Melissa TrudingerIn the biggest party the science community has ever seen, Australia was a wallflower.
Norwood makes a deal with Monash
19 March, 2002 by Tanya HollisImmunology therapies group Norwood Abbey has announced a research agreement with Monash University to develop and market its thymic manipulation technologies.
New pro-GM booklet launched
18 March, 2002 by Melissa TrudingerA booklet addressing gene technology issues was launched this week by Agrifood Awareness Australia - an industry alliance dedicated to increasing public awareness of gene technology.
EpiTan basks in glow of positive human trial results
18 March, 2002 by Tanya HollisAn Australian-made tanning drug has shown positive results in its first human trials.
Agenix dilutes stake in Singapore subsidiary
18 March, 2002 by Pete YoungListed Australian diagnostics biotech Agenix Ltd is diluting its stake in Singapore subsidiary PhytoProtein Biotech.
